Amy Abernethy, FDA’s principal deputy commissioner and acting CIO, and Mark McClellan, director of the Duke-Margolis Center for Health Policy at Duke University, described in podcast interviews with BioCentury’s Washington Editor Steve Usdin how the pandemic has accelerated progress on integrating real-world data and evidence into research and practice.

Getting Real about COVID-19 Data Part 1: A conversation with Amy Abernethy

Getting Real about COVID-19 Data Part 2: A conversation with Mark McClellan